Collaborative Stage for TNM 7 - Revised 08/18/2010  [ Schema ]

MelanomaSkin

CS Lymph Nodes Eval

CodeDescriptionStaging Basis
0Does not meet criteria for AJCC pathologic staging:  No regional lymph nodes, satellite nodule(s) or in-transit metastases (nodules) removed for examination.  Evidence based on physical examination, imaging examination, or other non-invasive clinical evidence.  No autopsy evidence used.c
1Does not meet criteria for AJCC pathologic staging:  No regional lymph nodes, satellite nodule(s) or in-transit metastases (nodules) removed for examination.  Evidence based on endoscopic examination, diagnostic biopsy including fine needle aspiration of lymph node(s), satellite nodule(s) or in-transit metastases (nodules) or other invasive techniques, including surgical observation without biopsy. No autopsy evidence used.c
2Meets criteria for AJCC pathologic staging:  No regional lymph nodes, satellite nodule(s) or in-transit metastases (nodules) removed for examination, but evidence derived from autopsy (tumor was suspected or diagnosed prior to autopsy).p
3Meets criteria for AJCC pathologic staging:  Regional lymph nodes, satellite nodule(s) or in-transit metastases (nodules) removed for examination (removal of at least one lymph node, satellite nodule(s) or in-transit metastasis) WITHOUT pre-surgical systemic treatment or radiation  OR lymph nodes, satellite nodule(s) or in-transit metastases (nodules) removed for examination, unknown if pre-surgical systemic treatment or radiation performed.p
5Does not meet criteria for AJCC y-pathologic (yp) staging:  Regional lymph nodes, satellite nodule(s) or in-transit metastases (nodules) removed for examination AFTER neoadjuvant therapy,  AND lymph node, satellite nodule(s) or in-transit metastases (nodules) evaluation based on clinical evidence, unless the pathologic evidence at surgery (AFTER neoadjuvant) is more extensive (see code 6).c
6Meets criteria for AJCC y-pathologic (yp) staging:  Regional lymph nodes, satellite nodule(s) or in-transit metastases (nodules) removed for examination AFTER neoadjuvant therapy,  AND lymph node(s), satellite nodule(s) or in-transit metastases (nodules) evaluation based on pathological evidence, because pathologic evidence at surgery is more extensive than clinical evidence before treatment.yp
8Meets criteria for AJCC autopsy (a) staging:  Evidence from autopsy; tumor was unsuspected or undiagnosed prior to autopsy.a
9Unknown if lymph nodes, satellite nodule(s) or in-transit metastases (nodules ) removed for examination
Not assessed; cannot be assessed
Unknown if assessed
Not documented in patient record
c